209 related articles for article (PubMed ID: 35618935)
1. Screening of organoids derived from patients with breast cancer implicates the repressor NCOR2 in cytotoxic stress response and antitumor immunity.
Tsai KK; Huang SS; Northey JJ; Liao WY; Hsu CC; Cheng LH; Werner ME; Chuu CP; Chatterjee C; Lakins JN; Weaver VM
Nat Cancer; 2022 Jun; 3(6):734-752. PubMed ID: 35618935
[TBL] [Abstract][Full Text] [Related]
2. BQ323636.1, a Novel Splice Variant to
Gong C; Man EPS; Tsoi H; Lee TKW; Lee P; Ma ST; Wong LS; Luk MY; Rakha EA; Green AR; Ellis IO; Lam EW; Cheung KL; Khoo US
Clin Cancer Res; 2018 Aug; 24(15):3681-3691. PubMed ID: 29420220
[No Abstract] [Full Text] [Related]
3. Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer.
Long MD; Jacobi JJ; Singh PK; Llimos G; Wani SA; Rowsam AM; Rosario SR; Hoogstraat M; Linder S; Kirk J; Affronti HC; Bergman A; Zwart W; Campbell MJ; Smiraglia DJ
Cell Rep; 2021 Dec; 37(11):110109. PubMed ID: 34910907
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.
Reichenbach J; Fraungruber P; Mayr D; Buschmann C; Kraus FBT; Topalov NE; Chelariu-Raicu A; Kolben T; Burges A; Mahner S; Kessler M; Jeschke U; Czogalla B; Trillsch F
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8719-8728. PubMed ID: 37131060
[TBL] [Abstract][Full Text] [Related]
5. Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation.
Mori T; Verma R; Nakamoto-Matsubara R; Siu KT; Panaroni C; Fulzele KS; Mukaihara K; Onyewadume C; Maebius A; Kato H; Wong LP; Sadreyev RI; Scadden DT; Raje NS
Blood Cancer J; 2021 Dec; 11(12):194. PubMed ID: 34864816
[TBL] [Abstract][Full Text] [Related]
6. HP1γ Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A.
Alam H; Li N; Dhar SS; Wu SJ; Lv J; Chen K; Flores ER; Baseler L; Lee MG
Cancer Res; 2018 Jul; 78(14):3834-3848. PubMed ID: 29764865
[TBL] [Abstract][Full Text] [Related]
7. SpliceArray profiling of breast cancer reveals a novel variant of NCOR2/SMRT that is associated with tamoxifen resistance and control of ERα transcriptional activity.
Zhang L; Gong C; Lau SL; Yang N; Wong OG; Cheung AN; Tsang JW; Chan KY; Khoo US
Cancer Res; 2013 Jan; 73(1):246-55. PubMed ID: 23117886
[TBL] [Abstract][Full Text] [Related]
8. CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.
van Agthoven T; Sieuwerts AM; Veldscholte J; Meijer-van Gelder ME; Smid M; Brinkman A; den Dekker AT; Leroy IM; van Ijcken WF; Sleijfer S; Foekens JA; Dorssers LC
Br J Cancer; 2009 Dec; 101(11):1824-32. PubMed ID: 19904269
[TBL] [Abstract][Full Text] [Related]
9. The pregnane X receptor (PXR) and the nuclear receptor corepressor 2 (NCoR2) modulate cell growth in head and neck squamous cell carcinoma.
Rigalli JP; Reichel M; Reuter T; Tocchetti GN; Dyckhoff G; Herold-Mende C; Theile D; Weiss J
PLoS One; 2018; 13(2):e0193242. PubMed ID: 29470550
[TBL] [Abstract][Full Text] [Related]
10. NADPH levels affect cellular epigenetic state by inhibiting HDAC3-Ncor complex.
Li W; Kou J; Qin J; Li L; Zhang Z; Pan Y; Xue Y; Du W
Nat Metab; 2021 Jan; 3(1):75-89. PubMed ID: 33462516
[TBL] [Abstract][Full Text] [Related]
11. Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence.
Smith CL; Migliaccio I; Chaubal V; Wu MF; Pace MC; Hartmaier R; Jiang S; Edwards DP; Gutiérrez MC; Hilsenbeck SG; Oesterreich S
Breast Cancer Res Treat; 2012 Nov; 136(1):253-65. PubMed ID: 23015261
[TBL] [Abstract][Full Text] [Related]
12. Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.
Zou G; Zhang X; Wang L; Li X; Xie T; Zhao J; Yan J; Wang L; Ye H; Jiao S; Xiang R; Shi Y
Theranostics; 2020; 10(15):6839-6853. PubMed ID: 32550907
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome.
Green AR; Burney C; Granger CJ; Paish EC; El-Sheikh S; Rakha EA; Powe DG; Macmillan RD; Ellis IO; Stylianou E
Breast Cancer Res Treat; 2008 Aug; 110(3):427-37. PubMed ID: 17902051
[TBL] [Abstract][Full Text] [Related]
14. ETV6 germline mutations cause HDAC3/NCOR2 mislocalization and upregulation of interferon response genes.
Fisher MH; Kirkpatrick GD; Stevens B; Jones C; Callaghan M; Rajpurkar M; Fulbright J; Cooper MA; Rowley J; Porter CC; Gutierrez-Hartmann A; Jones K; Jordan C; Pietras EM; Di Paola J
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32841218
[TBL] [Abstract][Full Text] [Related]
15. HDAC inhibitors sodium butyrate and sodium valproate do not affect human ncor1 and ncor2 gene expression in HL-60 cells.
Vrba J; Trtkova K; Ulrichova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):259-62. PubMed ID: 22286811
[TBL] [Abstract][Full Text] [Related]
16. Insights into the function of HDAC3 and NCoR1/NCoR2 co-repressor complex in metabolic diseases.
Paluvai H; Shanmukha KD; Tyedmers J; Backs J
Front Mol Biosci; 2023; 10():1190094. PubMed ID: 37674539
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (
Panagopoulos I; Andersen K; Gorunova L; Lund-Iversen M; Lobmaier I; Heim S
Cancer Genomics Proteomics; 2022; 19(2):163-177. PubMed ID: 35181586
[TBL] [Abstract][Full Text] [Related]
18. Giant Cell Tumors With HMGA2::NCOR2 Fusion : Clinicopathologic, Molecular, and Epigenetic Study of a Distinct Entity.
Perret R; Malaka Z; Velasco V; Llamas-Gutierrez F; Ropars M; Linck PA; Hostein I; Azmani R; Valo I; Galmiche L; Moreau A; de Pinieux G; Michot A; Bochaton D; Coindre JM; Le Loarer F
Am J Surg Pathol; 2023 Jul; 47(7):801-811. PubMed ID: 37170907
[TBL] [Abstract][Full Text] [Related]
19. KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer.
Tsoi H; Man EP; Leung MH; Mok KC; Chau KM; Wong LS; Chan WL; Chan SY; Luk MY; Cheng CN; Khoo US
Clin Transl Med; 2021 Oct; 11(10):e554. PubMed ID: 34709749
[No Abstract] [Full Text] [Related]
20. LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/NCOR2 axis in hepatocellular carcinoma cells.
Wu Y; Zhou Y; Huan L; Xu L; Shen M; Huang S; Liang L
Cancer Sci; 2019 Mar; 110(3):973-984. PubMed ID: 30680848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
